Oncogenesis and Neoplasia Flashcards
What are the cell cycle stages
G0
G1 - cell grows to full size
S - DNA synthesis
G2 - rapid cell contents productions
M - cell division
Cytokinesis
What does G1 checkpoint check for
nutrients
growth factors
DNA damage
What does G2 checkpoint check for
cell size
DNA replication
What does metaphase checkpoint check for
chromosome spindle attachment
why are cyclins degraded
avoid uncontrolled chain reactions
When do CDKs become active
bound to cyclins
What is the action of cyclin/CDK
phosphorylate Rb
Rb changes in conformation
RB uncouples from E2F
E2F acts as a TF for S phase gene transcription
Types of genes which are mutated in cancer
proto-oncogenes
oncogenes
tumour suppressor genes
What are proto oncogenes
genes that possess normal gene products and stimulate normal cell development
e.g. GF (C-Myc and K-Ras)
How do oncogenes form
gain of function mutation of protooncogenes
What are oncogenes
more active than normal or active at inappropriate times and stimulate unregulated cell proliferation
What is a tumour suppressor gene
gene that’s normal function is to constrain cell proliferation and partial or complete inactivation lead to an increased likelihood of cancer development
e.g. p53 and Rb
loss of function can cause cancer
When is p53 activated
DNA damage
cell cycle abnormalities
hypoxia
What is the function of normal p53
apoptosis
cell cycle arrest
DNA repair
cell cycle restart
mutant p53
present in >50% of all cancers, inhibits self removal of the mutant cells, prolongs propagation and proliferation
Two groups associated with tumorigenesis
gain of function - inappropriate activation of oncogenes
loss of function - inactivation of tumour suppressor genes
what are common properties of cancer cells
-resisting cell death
-sustaining proliferative signalling
-evading growth suppressors
-activating invasion and metastasis
-enabling replicative immortality
-inducing angiogenesis
What are the 6 steps of cancer diagnosis/progression defined at the molecular level
- self sufficiency of growth (overproducing GFs)
- do not respond to usual growth inhibitory signals e.g. cell cycle cycle checkpoints
- evasion of apoptotic mechanisms e.g. p53 mutations
- immortalisation e.g. loss of telomere shortening
- neoangiogenesis e.g. overproduction of VEGF for new vessels
- invasion and metastasis e.g. alterations in production of cellular adhesion molecules
What are the hallmarks of cancer
emerging: deregulating cellular energetics and avoiding immune destruction
enabling characteristics: genome instability and tumour promoting inflammation